A double-blind, placebo-controlled study of monoclonal anti-interleukin-2 receptor antibody (BT563) administration to prevent acute rejection after kidney transplantation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples